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Abstract: Objective: This study aimed to investigate the quantitative effects of outdoor air 
pollution, represented by 10 µg/m
3 increment of PM10, on chronic obstructive pulmonary 
disease in China, United States and European Union through systematic review and   
meta-analysis. Methods: Publications in English and Chinese from PubMed and EMBASE 
were selected. The Cochrane Review Handbook of Generic Inverse Variance was used to 
synthesize the pooled effects on incidence, prevalence, mortality and hospital admission. 
Results: Outdoor air pollution contributed to higher incidence and prevalence of COPD. 
Short-term exposure was associated with COPD mortality increased by 6%, 1% and 1% in 
the European Union, the United States and China, respectively (p < 0.05). Chronic PM 
exposure produced a 10% increase in mortality. In a short-term exposure to 10 µg/m
3 PM10 
increment COPD mortality was elevated by 1% in China (p < 0.05) and hospital admission 
enrollment was increased by 1% in China, 2% in United States and 1% in European Union 
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(p < 0.05). Conclusions: Outdoor air pollution contributes to the increasing burdens of 
COPD.10 µg/m
3 increase of PM10 produced significant condition of COPD death and 
exacerbation in China, United States and European Union. Controlling air pollution will 
have substantial benefit to COPD morbidity and mortality. 
Keywords: ambient air pollution; chronic obstructive pulmonary disease; environmental 
health; epidemiology; particulate matter 
 
1. Introduction 
Chronic obstructive pulmonary disease (COPD) is one of the leading health burdens worldwide, 
accounting for 3.0 million deaths annually [1]. Up to 2010, COPD was still the leading cause of deaths, 
and among the top 5 causes for years of life lost in East and South Asia [2,3]. Globally there are  
210 million people suffering from COPD [4]. Without effective intervention, the deaths from COPD 
will increase by more than 30% in the next decade [4]. The major risk factors of COPD includes 
tobacco smoking, outdoor air pollution and indoor air pollution from biomass fuel burning [4–6]. From 
some systematic reviews, exposing to indoor air pollution introduced a more than 2-fold risk of COPD, 
tobacco smoking definitely increased the risk of chronic respiratory diseases and smoking cessation 
was an effective strategy for COPD treatment [7–10]. However, the effects from outdoor air pollution 
on COPD burdens and exacerbation were seldom reported from systematic reviews. Reports of the 
efficacy of air control strategies on prevention of chronic pulmonary diseases were few. Recently, 
China faces a huge challenge in outdoor air pollution and chronic respiratory diseases become main 
issues threatening Chinese people’s health. Verifying the efficacy of air quality improvement on 
COPD burdens, especially significant reductions of particulate matter (PM), is meaningful to Chinese 
policymakers. This study aimed to quantitatively assess the contribution from outdoor air pollution to 
COPD burdens, in order to present a goal and evidence of improving air quality. 
2. Experimental Section  
2.1. Data Sources 
Databases: PubMed and EMBASE were the target databases. PubMed was accessed through NCBI 
(from 1January 1980 to 31 March 2012) [11]. EMBASE was accessed via Harvard (from 1980 to  
2012) [12].We selected the publications investigating the effects of outdoor air pollution on COPD,  
in terms of incidence, prevalence, mortality and hospital admission.  
2.2. Search Terms and Strategy to Select Articles 
Search terms: 
(1)  Ambient air pollution 
(2)  Urban air pollution 
(3)  Outdoor air pollution Int. J. Environ. Res. Public Health 2014, 11  11824 
 
 
(4)  COPD 
(5)  Chronic obstructive pulmonary disease 
(6)  Chronic bronchitis 
(7)  Emphysema 
In all fields search: 
“(1) AND (4)” OR “(1) AND (5)” OR “(1) AND (6)” OR “(1) AND (7)” OR “(2) AND (4)” OR 
“(2) AND (5)” OR “(2) AND (6)” OR “(2) AND (7)” OR “(3) AND (4)” OR “(3) AND (5)” OR  
“(3) AND (6)” OR “(3) AND (7)”. 
2.3. Study Selection 
COPD includes chronic bronchitis and emphysema [4]. For the complexity of outdoor air, PM was 
chosen as the indicator of outdoor air quality [13]. Inclusion criteria were definition of COPD   
(ICD-10:J41–44), language (Chinese and English), study design (cohort, case-control, cross-sectional 
and time-series), original reports, relative risk and 95% confidence interval (95%CI) of PM. The 
exclusion criteria were reanalysis of previous data, review and comments to related study.  
2.4. Data Extraction and Quality Assessment 
The items of publication year, study design, study field, subjects setting, exposure, outcome, effect 
size, and adjusted factors were all extracted.In case of the collinearity, the extracted effect estimate of 
PM did not adjust any other pollutants in outdoor air.PM was classified as total suspended particulates 
(TSP, particulates less than 40 μm in diameter), inhalable particulates (PM10, particulates less than  
10  μm in diameter), coarse particulates (particulates less than 10 μm but higher than 2.5 μm in 
diameter), fine particulates (PM2.5, particulates less than 2.5 μm in diameter) and ultra-fine particulates 
(PM0.1, particulates less than 0.1 μm in diameter). Most studies investigated PM10, and it was set as the 
representative of PM. Study characteristics of eligible articles were exhibited for quality assessment. 
2.5. Data Synthesis 
Review Manager (RevMan) is The Cochrane Collaboration’s software for preparing and 
maintaining Cochrane reviews. We used 5.0 version to measure the pooled effect. “Generic Inverse 
Variance” method was recommended to synthesize data in non-randomized studies [14]. If any studies 
provided the effect estimate of subgroups, the pooled effect was estimated across subgroups:   
the procedure can be interpreted as a meta-analysis at the level of an individual study [14]. Most 
studies investigating the acute effect in 2 days after air quality change, so the average estimate in lag 
0–2 day was estimated. In addition, RevMan 5 provided estimates of the heterogeneity. We used Chi
2 
to assess the heterogeneity that p-value of Chi
2 < 0.05 indicated significant heterogeneity. The random 
analysis model was used for the significant heterogeneity and the fixed analysis model was introduced 
for non-significant heterogeneity [15]. Publication biases between studies were assessed by funnel plot. 
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3. Results 
In total 351 articles were identified by titles and abstracts and 67 were further assessed in details. 
Finally 44 studies were included in the study (Supplemental Figure S1). The included studies were 
published after 1990s and most were time-series designs (Supplemental Table S1). Among the studies 
on mortality, the cohort and cross-sectional study assessed the chronic effect of PM, and the case 
crossover and time-series studies analyzed the acute effect of PM (less than 7-day exposure) 
(Supplemental Table S1). Though these studies had adjustments of confounding factors (Supplemental 
Table S1), the observatory design still introduced median risk of bias. And some publications defined 
COPD by the symptoms not the lab tests, which was possible to have a high risk of bias. 
3.1. Outdoor Air Pollution to COPD Incidence 
One cohort study in California showed a 1.33-fold high risk of incidence from a more than   
200μg/m
3 TSP exposure. A nested case-control study in Athens, found the risk increased to 1.37 from 
a quartile increase of black smoke exposure. 
3.2. Outdoor Air Pollution to COPD Prevalence 
Three studies investigated the contribution to prevalence. Exposing to high level PM, pooled 
prevalence risk was increased by 11%, and heterogeneity was not significant (Figure 1).  
Figure 1. The effect of outdoor air pollution on COPD prevalence. 
 
3.3. Outdoor Air Pollution to COPD Mortality 
Fourteen studies investigated the contribution to mortality. A 3% higher risk was observed for 
COPD death but the heterogeneity was significant (Figure 2). 
In different study designs, cohort studies observed an 11% higher risk from long-term exposure to 
exacerbating outdoor air pollution and case crossover studies observed a 1% higher risk in short-term 
exposure for COPD death (Table 1). In various regions, the pooled risk was 1.07 in EU and 1.01 in 
China from higher PM exposure; the heterogeneity was non-significant (Table 1). Short-term exposing 
to 10µg/m
3 increment of PM10 produced a 1% higher acute death in China (Table 1). 
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Figure 2. The effect of outdoor air pollution on COPD mortality. 
 
Table 1. Subgroup analysis for the contribution of outdoor air pollution to COPD mortality *. 
Category 
Study Characteristics 
(Number of Studies) 
Summary Estimate  Summary Estimate  I
2 
Study design 
Cohort (2)  1.11  1.07~1.15  0%
# 
Case crossover (3)  1.01  1.00~1.01  42%
# 
Ecological study (8)  1.02  1.01~1.03  57% 
Cross sectional (1)  1.09  1.06~1.12  NA 
Research field 
EU (4)  1.07  1.04~1.11  0%
# 
US (4)  1.03  1.00~1.06  84% 
China (4)  1.01  1.00~1.01  3%
# 
others (2)  1.06  1.02~1.11  87% 
PM size 
PM10 (11)  1.02  1.01~1.04  76% 
TSP (3)  1.07  1.01~1.13  79% 
PM increment 
PM10 10 ug/m
3 increment (8)  1.02  1.01~1.03  76% 
Others (6)  1.08  1.04~1.12  58% 
The effect of 10 ug/m
3 PM10 
increment in different areas 
China (3)  1.01  1.00~1.01  0%
# 
US (3)  1.03  1.00~1.06  87% 
EU (1)  1.04  0.99~1.06  NA 
Others (1)  1.04  1.02~1.06  NA 
Effect duration 
Chronic effect (3)  1.10  1.07~1.12  0%
# 
Acute effect (11)  1.02  1.01~1.03  59% 
Acute effects in different areas 
China (4)  1.01  1.00~1.01  3%
# 
EU (3)  1.06  1.02~1.11  0%
# 
US (3)  1.01  1.01~1.02  56%
# 
* The significance level for heterogeneity was·0.05; 
# non-significant. Int. J. Environ. Res. Public Health 2014, 11  11827 
 
 
Based on exposure term, long-term exposure (chronic effect) resulted in a 10% increase for 
mortality and short-term exposure (acute effect) introduced the death increased by 1% higher in China, 
6% higher in EU and 1% higher in US (Table 1). 75% studies in China and US analyzed the acute 
effect of 10 µg/m
3 PM10 increase, in contrast with 25% studies in EU. The other studies in EU 
investigated the chronic effect and the acute effect of more than 20 µg/m
3 PM10 increase. 
3.4. Outdoor Air Pollution and Hospital Admission for COPD 
From Figure 3, the included studies presented the acute effect of exposure and the total effect 
estimate of hospital admissions was 1.02 with 95% CI: 1.01–1.02. The subgroup analysis by study 
design, research fields and PM size did not reduce the heterogeneities; but short-term exposing to 
10 ug/m
3 increment of PM10 led to the hospital admission increased by 1% in China, 2% in US and 1% 
in EU, and the heterogeneity was non-significant (Table 2). 
Figure 3. The effect of outdoor air pollution on COPD hospital admission. 
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3.5. Publication Bias 
The publication bias was tested by funnel plots among the time-series studies about mortality and 
all the studies about hospital admission (Supplemental Figures S2 and S3). For mortality, the missing 
studies appeared in areas of 0.05 < p < 0.10; for hospital admission, the supposed missing studies were 
in area of p < 0·05. And when we funnel plotted the studies about hospital admission of 10 μg/m
3 
increase of PM10, almost all study plots were on the effect estimate line. Most missing studies were in 
the significant level, so the asymmetry of funnel plots was probably not caused by publication bias. 
Table 2. Subgroup analysis for the contribution of outdoor air pollution to hospital 
admission for COPD *. 
Category 
Study Characteristics 
(Number of Studies) 
Summary 
Estimate 
Summary 
Estimate 
I
2 
Study Design 
Case-crossover (4)  1.11  1.00 ~ 1.23  84% 
Ecological study (23)  1.02  1.01 ~ 1.02  64% 
Research Field 
US (10)  1.02  1.01 ~ 1.03  71% 
EU (8)  1.02  1.01 ~ 1.04  61% 
China (5)  1.01  1.01 ~ 1.02  80% 
Others (4)  1.05  1.02 ~ 1.08  46% 
# 
PM size 
PM10 (19)  1.02  1.01 ~ 1.02  72% 
Others (8)  1.02  1.01 ~ 1.03  60% 
PM increment 
PM10 10 ug/m
3 increment (9)  1.01  1.01 ~ 1.01  16% 
# 
Others (18)  1.03  1.02 ~ 1.05  75% 
The effect of 10 ug/m
3 PM10 
increment in different areas 
china (3)  1.01  1.01 ~ 1.01  46% 
# 
US (4)  1.02  1.01 ~ 1.03  0% 
# 
EU (2)  1.01  1.00 ~ 1.02  59% 
# 
* The significant level for heterogeneity was 0.05; 
# non-significant. 
4. Discussion 
Smoking and indoor air pollution introduced increasing risk to COPD. In this study, PM exposures 
from outdoor air pollution definitively increased COPD burdens. Ten μg/m
3 increase of PM 10 was 
related with higher risk of COPD death and hospital admission. 
PM exposure could induce biological changes in respiratory system. PM suspensions increased 
airway hyper-responsiveness to acetylcholine and reduced host defense in rodents; the exposure released 
neutrophil influx, bronchoalveolar lavage protein and cytokine in lung tissues [16]. Ambient air particles 
could induce the production of reactive oxygen and inflammatory factors in alveolar macrophages [17–19], 
polymorphonuclear granulocytes [20] and bronchial epithelial cells [21]. The reactive oxygen species, 
inflammatory factor production and respiratory inflammation, played important roles in lung tissue 
injury and higher risk of COPD. 
The relative risk for incidence was observed higher than prevalence. The studies on COPD 
incidence investigated TSP of higher than 200μg/m
3 [22] and black smoke of more than 10 μg/m
3 
increase [23] but the studies on COPD prevalence analyzed PM2.5 of 1 μg/m
3 increase [24] and TSP of 
10 μg/m
3 increase [25]. Higher exposure might introduce a higher effect. Additionally, PM increase in Int. J. Environ. Res. Public Health 2014, 11  11829 
 
 
outdoor air pollution was associated with a higher risk of death, and the severe cases might die due to 
the exposure and old age. Therefore, a lower effect estimate was observed in prevalent cases than 
incident cases. The stronger contribution to prevalence in China than Western countries is likely 
related to the severe air quality in China [26]. 
The acute effect of mortality was a little higher in EU than US and China, which was the result of 
different exposure characteristics: the studies in China and US analyzed the effect of lower level 
exposure than the studies in EU. The chronic effect of outdoor air pollution on COPD mortality was 
much more severe than acute effect, because of longer exposure time.The increase of hospital 
admission for COPD after the outdoor air pollution rise suggested that outdoor air pollution affected 
the exacerbation of COPD status.  
When a funnel plot was used to detect the publication bias in this analysis, it seemed that the plots 
were somewhat visually asymmetrical. The asymmetry indicated there were small-study effects in the 
analysis [14]. Though some statistical methods were recommended by the Cochrane center for testing 
the asymmetry of funnel plot, the methods had relatively low power and were recommended in 
randomized control trials [14]. Therefore, we chose contour enhanced funnel plot to test the 
publication bias [14]. For the missing studies in significant areas, the asymmetry of funnel plot might 
not be the result of publication bias, but the heterogeneity and the artefactual: the association between 
effect estimate and standard error [14]. 
The inclusion of non-randomized studies was the primary limitation in this study. The Handbook 
Review of Cochrane still provided analytical methods for non-randomized studies. As suggested from 
Cochrane, generic inverse variation was selected to synthesize the data from non-randomized studies 
and the study characteristics were presented [14]. In contrast to randomized control trials, confounding 
bias was one of the key issues in non-randomized studies.  
The primary risk factors for COPD were tobacco smoking, indoor air pollution (such as biomass 
fuels), outdoor air pollution and occupational dusts and chemicals [4], and most of the included studies 
controlled these risk factors. Two cohorts failed to control the effects of tobacco smoking, but smoking 
appeared not to act as a confounder in analyses [27,28]. The case crossover and time series studies 
analyzed the acute effects of outdoor air pollution on COPD and in such a short term, smoking habit 
and biomass fuel usage were not possible to change seriously. Misclassification of exposure and 
outcome was another possible limitation in this analysis. In the included studies, the data of exposure 
to PM was provided by the government environmental department, who monitored the outdoor air 
quality and the diagnosis of COPD was defined in hospitals. The non-random design and potential risk 
of bias introduced the limitation in this study. 
5. Conclusions 
High level outdoor air pollution was associated with an increase of COPD incidence and 
prevalence. A 10 μg/m
3 increase of PM10 in outdoor air can induce significant acute exacerbations and 
mortality in COPD. This study provides evidence for the need for air quality improvement and 
continual assessment. It is time to take action to improve air quality. 
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Strengths 
This study integrated the studies in both English and Chinese and presented the effect of PM 
pollution in Western Countries and China. Besides of the significant effect of PM on COPD burden,  
it showed the contribution of 10µg/m
3 increased to COPD death and exacerbation. It estimated the 
acute and chronic effect of PM increase on COPD death. 
It provided a quantitative evidence for government, especially for China to set up an air quality plan 
to achieve an acceptable goal in COPD control. 
Limitations 
It included non-randomized studies. Most of the included studies were ecological design, which did 
not control the risk factors of smoking and indoor air pollution. 
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